Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/245438
Share/Export:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Title

Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC)

AuthorsSanoja-Flores, L.; Flores-Montero, Juan; Garcés, Juan-Jose; Paiva, Bruno; Puig, Noemi; García-Mateo, Aránzazu; García-Sánchez, O.; Corral-Mateos, A.; Burgos, Leire; Blanco, Elena; Hernández-Martín, J.; Pontes, R.; Díez-Campelo, María; Millacoy, Pamela; Rodríguez-Otero, Paula; Prosper, Felipe; Merino, J.; Vidriales, Maria Belén; García-Sanz, Ramón; Romero, Alfonso; Palomera, Luis; Ríos-Tamayo, R.; Pérez-Andrés, Martin; Blanco, Juan F.; González, Marcos CSIC ORCID ; Dongen, J. J. M. van; Durie, B.; Mateos, Maria Victoria; San-Miguel, Jesús; Orfao, Alberto CSIC ORCID
KeywordsMyeloma
Risk factors
Issue Date2018
PublisherSpringer Nature
CitationBlood Cancer Journal 8: 117 (2018)
AbstractHere, we investigated for the first time the frequency and number of circulating tumor plasma cells (CTPC) in peripheral blood (PB) of newly diagnosed patients with localized and systemic plasma cell neoplasms (PCN) using next-generation flow cytometry (NGF) and correlated our findings with the distinct diagnostic and prognostic categories of the disease. Overall, 508 samples from 264 newly diagnosed PCN patients, were studied. CTPC were detected in PB of all active multiple myeloma (MM; 100%), and smoldering MM (SMM) patients (100%), and in more than half (59%) monoclonal gammopathy of undetermined significance (MGUS) cases (p <0.0001); in contrast, CTPC were present in a small fraction of solitary plasmacytoma patients (18%). Higher numbers of CTPC in PB were associated with higher levels of BM infiltration and more adverse prognostic features, together with shorter time to progression from MGUS to MM (p <0.0001) and a shorter survival in MM patients with active disease requiring treatment (p ≤ 0.03). In summary, the presence of CTPC in PB as assessed by NGF at diagnosis, emerges as a hallmark of disseminated PCN, higher numbers of PB CTPC being strongly associated with a malignant disease behavior and a poorer outcome of both MGUS and MM.
Description© The Author(s) 2018.
Publisher version (URL)http://dx.doi.org/10.1038/s41408-018-0153-9
URIhttp://hdl.handle.net/10261/245438
DOI10.1038/s41408-018-0153-9
E-ISSN2044-5385
Appears in Collections:(IBMCC) Artículos

Files in This Item:
File Description SizeFormat
Next_Sanoja_PV_Art2018.pdf1,12 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work

PubMed Central
Citations

17
checked on Jan 12, 2022

SCOPUSTM   
Citations

30
checked on Jan 19, 2022

WEB OF SCIENCETM
Citations

30
checked on Jan 20, 2022

Page view(s)

45
checked on Jan 23, 2022

Download(s)

18
checked on Jan 23, 2022

Google ScholarTM

Check

Altmetric

Dimensions


Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.